3rd Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$339,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and remimbursement Medicaid Coverage

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
BRANTLEY CARLSON —
MARIA FIRVIDA —
JULIE GARNER —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834)

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
BRANTLEY CARLSON —
MARIA FIRVIDA —
JULIE GARNER —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1628 (115th)

Pharmacy PHA

Prescription Drug User Fee Act - implementation and general legislative planning

LobbyistCovered position, as disclosed
MARIA FIRVIDA —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.